https://www.selleckchem.com/pr....oducts/cilofexor-gs-
Adjunctive psychostimulants have been proposed as a potential treatment option for the management of cognitive and/or negative symptoms of schizophrenia. The present study is a retrospective review of use of adjunctive psychostimulants among outpatients enrolled in our tertiary Schizophrenia Program between 2014 and 2019. We assessed response to treatment, adverse effects, and the impact of various clinical factors on treatment outcome. Of the 77 (out of 1,30 participants prescribed psychostimulants during the study period,
Like
Comment
Share
